To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Feeling abandoned as rehab centers replaced pill mills, residents of Portsmouth, Ohio hit the gym to fight back.
Purdue Pharma, the maker of OxyContin, declared bankruptcy as part of a tentative deal to settle more than 2,000 lawsuits alleging that they and other opioid manufacturers worsened the US opioid epidemic.
The opioid crisis is not just an American problem; it’s a global one.
Spinraza, a newly approved drug for spinal muscular atrophy has faced slow ramp-ups at hospitals and resistance by health insurers spooked by the $750,000 list price.